Peripheral Nerve Stimulation and Clinical Outcomes: A Retrospective Case Series
Autor: | Matthew A. Warner, Markus A. Bendel, Kalli K. Schaefer, Tim J. Lamer, Jason S. Eldrige, Matthew J. Pingree, Nafisseh S. Warner, Richard H. Rho, William D. Mauck |
---|---|
Rok vydání: | 2020 |
Předmět: |
Adult
Peripheral nerve stimulation Analgesic Stimulation 03 medical and health sciences 0302 clinical medicine 030202 anesthesiology Occipital neuralgia medicine Humans Peripheral Nerves Prospective Studies Retrospective Studies business.industry Chronic pain medicine.disease Neuromodulation (medicine) Treatment Outcome Anesthesiology and Pain Medicine Opioid Anesthesia Transcutaneous Electric Nerve Stimulation Neuralgia business Surgical site infection 030217 neurology & neurosurgery medicine.drug |
Zdroj: | Pain Practice. 21:411-418 |
ISSN: | 1533-2500 1530-7085 |
DOI: | 10.1111/papr.12968 |
Popis: | PURPOSE Peripheral nerve stimulation (PNS) is a rapidly expanding field within neuromodulation; however, there is limited data on therapeutic efficacy. This study describes the indications and clinical outcomes for patients undergoing PNS for chronic pain states. PATIENTS AND METHODS This is a retrospective case series of adults undergoing PNS implantation from 2004 to 2017 at an academic medical center. The primary outcomes were changes in numeric rating scale (NRS) pain scores, opioid utilization in oral morphine milligram equivalent (MME), and self-reported patient functioning at 6 months postoperatively. Infectious and device-related complications were also assessed. RESULTS A total of 72 patients underwent PNS implantation, including 59 patients that received a preceding PNS trial (59/78; 76% progression rate) and 13 that did not receive a PNS trial. The most common indication for stimulation was occipital neuralgia (47%) followed by lower-extremity neuropathies (17%). PNS implantation was associated with 6-month reductions in pain scores (7 [6, 8] baseline vs. 4 [2, 5] 6 months; P |
Databáze: | OpenAIRE |
Externí odkaz: |